Drug Database
BE

bexarotene (Targretin Gel)

✓ Approved

Eisai Co., Ltd. · RXRA · 小分子

什么是 bexarotene?

bexarotene 是一种小分子,由Eisai Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Targretin Gel
公司Eisai Co., Ltd.
药物类别小分子
分子靶点RXRA, RXRB, RXRG
给药途径Topical
状态Approved

作用机制

分子靶点

bexarotene 作用于 3 个分子靶点:

RXRAretinoid X receptor alpha (RXR-alpha, RXRalpha)
RXRBretinoid X receptor beta (DAUDI6, H-2RIIBP)
RXRGretinoid X receptor gamma (RXR-gamma, RXRC)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

bexarotene 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Cutaneous T-cell lymphoma✓ Approved

相关研究文献

PubMedChemical communications (Cambridge, England)2026-11-17

Gutter-layer-free ion-gel thin-film composite membranes for high-performance CO2 separation.

Hoshihara Tenma T, Akita Saki S, Matsuoka Atsushi A, Nakagawa Keizo K et al.

A gutter-layer-free ion-gel thin-film composite (TFC) membrane was developed using a sacrificial polystyrene layer. Eliminating the conventional gutter layer removed hidden mass-transfer resistance, enabling the fabrication of a TFC membrane with thin ion-gel layers (∼0.8 µm) with CO2 permeance exceeding 1500 GPU while maintaining high CO2/N2 permselectivity (∼40).

PMID 43042640
阅读全文 →
PubMedPharmaceutical development and technology2026-11-17

Thermosensitive in situ nasal gel of Magnoliae Flos-Centipeda Herba for allergic rhinitis: preparation, characterization, and in vivo pharmacodynamics and pharmacokinetics studies.

Ma Yuxuan Y, Wang Zelong Z, Kang Baorong B, Xia Qingyun Q et al.

Magnoliae Flos and Centipeda Herba are classic herbal medicines for allergic rhinitis in traditional Chinese medicine, yet conventional nasal drops suffer from rapid clearance by nasal mucocilia, leading to limited nasal residence time. Herein, a thermosensitive in situ gel loaded with Magnoliae Flos and Centipeda Herba extract (MFCH-TGL) was fabricated to achieve prolonged, safe intranasal delivery. The gel matrix was composed of 17% (w/v) poloxamer 407 and 1% (w/v) poloxamer 188, incorporated with 2.3% (w/v) alcoholic extract and 0.5% (v/v) volatile oil of MFCH. We systematically characterized sol-gel transition performance, rheological behavior, in vitro release and ex vivo nasal permeation, and further assessed anti-allergic pharmacodynamics in BALB/c mice as well as nasal pharmacokinetics in SD rats. The formulation exhibited a sol-gel transition at 33.5 °C within 17 s, with 40.6 ± 1.97% cumulative nasal permeation over 8 h. Medium-dose MFCH-TGL markedly reduced OVA-specific IgE (8.28 ± 1.64, P < 0.01) compared with the allergic model group (12.55 ± 1.86). Moreover, the gel displayed 1.46-fold longer half-life and 1.52-fold longer mean residence time than the MFCH aqueous solution. This thermosensitive in situ gel presents promising intranasal application potential, offering a feasible formulation strategy for traditional Chinese medicine against allergic rhinitis.

PMID 43042950
阅读全文 →
PubMedBMC oral health2026-11-17

In vivo evaluation of magnesium gel on collagen fibril diameter in advanced palatal wound healing.

Elkaramany Samar M SM, Aly Hanaa M HM, Younes Salwa Abd El Samad SAES, Hamza Sara A SA et al.

Palatal wounds created during dental procedures can cause pain, delayed healing, and patient discomfort. Finding safe materials that improve healing is important for better recovery after oral surgery. Magnesium, an essential cofactor in more than 300 biochemical reactions, plays a key role in energy metabolism and cellular function. Despite advances in wound management, no standardized therapy has been established to consistently improve wound healing and reduce associated complications. In this study, magnesium gel was developed to evaluate its effect on collagen remodeling at advanced palatal wound healing. Thirty-six albino rats were equally divided into three groups. Palatal excisional wounds were induced. Group A received no treatment, Group B and group C were treated immediately with plain gel, and Mg gel respectively. Animals were sacrificed at 7, and 14 days postoperatively. Wound closure was assessed photographically, and specimens were analyzed histologically, morphometrically, and ultra structurally. Data was analyzed using one-way ANOVA test. The most rapid healing was demonstrated at group C (Mg gel) on both 7 and 14 days. Group C exhibited the smallest epithelial gap on day 7, along with superior epithelial organization and the thickest collagen fiber deposition on day 14. Magnesium gel appears to be a promising therapy for enhancing oral wound repair and collagen fiber remodeling.

PMID 43040338
阅读全文 →
PubMedACS nano2026-11-17

Structure-Engineered Lipid-Mineral Nanoparticles for Ligand-Free Myeloid RNAi Delivery in Alzheimer's Disease.

Shi Kexin K, Zhang Chenyun C, Chen Yaoxing Y, Li Haixia H et al.

Peripheral myeloid cells are key regulators of systemic inflammation and promising targets for immune intervention in Alzheimer's disease (AD). However, selective in vivo small interfering RNA (siRNA) delivery to these cells remains challenging because conventional lipid nanoparticles often exhibit predominant hepatic accumulation and usually require ligand or antibody modification for immune-cell targeting. Here, we report a structure-engineered lipid-mineral nanoparticle platform, termed MCP, for ligand-free myeloid RNA interference (RNAi) delivery. MCP integrates a calcium phosphate mineral phase with a phosphatidic acid-enriched lipid interface, enabling efficient siRNA incorporation. The Ca2+-lipid cooperative architecture promoted macropinocytosis-dependent uptake and preferential siRNA delivery to peripheral myeloid cells in vivo, particularly Ly6Chigh monocytes and macrophages, with enhanced delivery under AD-associated inflammatory conditions. Systemic delivery of MCP carrying siRNA against triggering receptor expressed on myeloid cells 1 (TREM1) attenuated neuroinflammatory and neurodegenerative pathology in an AD mouse model, supporting peripheral myeloid reprogramming as a route to modulate central nervous system (CNS) disease progression. Notably, MCP also achieved efficient TREM1 silencing in AD patient-derived peripheral blood mononuclear cells (PBMCs) and restored TREM1 expression toward healthy-control levels. This work establishes a structure-driven, ligand-free lipid-mineral RNAi platform for peripheral immune intervention in AD.

PMID 43043232
阅读全文 →
PubMedMaterials horizons2026-11-17

Surface chemistry of zirconia and hafnia colloidal nanocrystals: from fundamentals to applications.

Salazar Marcano David E DE, Maksimova Elizaveta E, Chaon Ian I, De Roo Jonathan J

Zirconia (ZrO2) and hafnia (HfO2) colloidal nanocrystals (NCs) have attracted interest in various areas from medicine to electronics and catalysis. For each application, the ligand shell needs to be carefully engineered since the interactions of NCs with each other and their environment are dictated by their complex surface. This starts with understanding what is present on the surface of as-synthesized NCs depending on the synthesis method. In this review, we provide a detailed overview of ligand binding and exchange on the surface of ZrO2 and HfO2 NCs. We draw a contrast between nonaqueous and aqueous media due to solvent-dependent differences in ligand binding. Moreover, we demonstrate how fundamental insights into the surface chemistry impact the design and performance of these NCs as radioenhancers, X-ray computed tomography contrast agents, fluorescence bioimaging probes, electronic/optical components, inorganic fillers for dental materials, or catalysts.

PMID 43042508
阅读全文 →
PubMedFood chemistry: X2026-11-17

Antarctic krill oil-in-water Pickering emulsions stabilized by bighead carp myofibrillar proteins enable coordinated enhancement of texture and flavor in shrimp surimi gels.

Zheng Zihan Z, Li Qingqing Q, Cheng Linli L, Wei Mengyuan M et al.

Improving texture without compromising desirable flavor remains a major challenge in the development of high-quality shrimp surimi products. However, previous studies have mainly focused on the effects of emulsified lipids on gel properties, while their role in regulating volatile flavor formation and release remains insufficiently understood. This study aimed to elucidate how bighead carp myofibrillar protein-stabilized Antarctic krill oil-in-water Pickering emulsions (BCMPPEs) simultaneously regulate the structural and flavor quality of shrimp surimi gels (SSGs). Increasing BCMPPE substitution enhanced whiteness, gel strength, hardness, chewiness, and gumminess, while altering water distribution and promoting the formation of a denser and more homogeneous protein network with smaller pores. Sensory quality increased from 63.3 to 73.9. Electronic nose analysis showed substitution-dependent changes in volatile release, while gas chromatography-ion mobility spectrometry (GC-IMS) identified 40 volatile compounds. Increasing BCMPPE incorporation shifted the volatile profile toward aldehyde-dominated compounds, selectively enriched flavor-active furanones, and reduced several alcohols, ketones, and esters. These findings indicate that protein-stabilized Antarctic krill oil droplets can serve as active structural components that reinforce the surimi gel network while modulating flavor-compound retention and release, providing a potential strategy for the coordinated improvement of texture and flavor in shrimp surimi products.

PMID 43042007
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多bexarotene